Rankings
▼
Calendar
EOLS Q4 2016 Earnings — Evolus, Inc. Revenue & Financial Results | Market Cap Arena
EOLS
Evolus, Inc.
$338M
Q4 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$4M
Net Income
-$4M
EPS (Diluted)
$-0.20
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$1M
Free Cash Flow
-$1M
Stock-Based Comp.
$313,000
Balance Sheet
Total Assets
$77M
Total Liabilities
$85M
Stockholders' Equity
-$7M
Cash & Equivalents
$0
← FY 2016
All Quarters
Q1 2017 →
